Clinical Trial Detail

NCT ID NCT03354390
Title HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Heart, Lung, and Blood Institute (NHLBI)
Indications

clear cell renal cell carcinoma

Therapies

Autologous HERV-E TCR transduced T cells

Age Groups: adult senior

No variant requirements are available.